Related references
Note: Only part of the references are listed.Mitochondrial Fragmentation Triggers Ineffective Hematopoiesis in Myelodysplastic Syndromes
Yasushige Aoyagi et al.
CANCER DISCOVERY (2022)
RUNX1mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses
Shady Adnan Awad et al.
LEUKEMIA (2021)
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia
Wenbin Xiao et al.
BLOOD (2021)
Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia
Audrey N. Jajosky et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies
Melanie Decker et al.
LEUKEMIA (2021)
Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation
Michelle C. Krutein et al.
BLOOD ADVANCES (2021)
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia
Yotaro Ochi et al.
NATURE COMMUNICATIONS (2021)
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation
Nico Gagelmann et al.
BLOOD ADVANCES (2021)
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes
Rashmi Kanagal-Shamanna et al.
CANCER (2021)
The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy
Claire C. Homan et al.
HAEMATOLOGICA (2021)
RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner
Mohamed Gaber Abdallah et al.
LEUKEMIA (2021)
Core binding factor acute myelogenous leukemia-2021 treatment algorithm
Gautam Borthakur et al.
BLOOD CANCER JOURNAL (2021)
Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia
Janghee Woo et al.
HAEMATOLOGICA (2020)
Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes
Guillermo Montalban-Bravo et al.
LEUKEMIA (2020)
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML
Laura Simon et al.
BLOOD (2020)
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
A. Hochhaus et al.
LEUKEMIA (2020)
How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies
David Wu et al.
HAEMATOLOGICA (2020)
Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunity
Wooseok Seo et al.
NATURE COMMUNICATIONS (2020)
Combined Cohesin-RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic Syndromes
Yotaro Ochi et al.
CANCER DISCOVERY (2020)
Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs
Tomoya Muto et al.
NATURE IMMUNOLOGY (2020)
Cooperating, congenital neutropenia associated Csf3r and Runx1 mutations activate pro-inflammatory signaling and inhibit myeloid differentiation of mouse HSPCs
Malte Ritter et al.
ANNALS OF HEMATOLOGY (2020)
Accurate germline RUNX1 variant interpretation and its clinical significance
Simone Feurstein et al.
BLOOD ADVANCES (2020)
Runx1 negatively regulates inflammatory cytokine production by neutrophils in response to Toll-like receptor signaling
Dana C. Bellissimo et al.
BLOOD ADVANCES (2020)
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
Anna L. Brown et al.
BLOOD ADVANCES (2020)
Hypoxia/pseudohypoxia-mediated activation of hypoxia-inducible factor-1 in cancer
Yoshihiro Hayashi et al.
CANCER SCIENCE (2019)
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1
Christopher P. Mill et al.
BLOOD (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
Susan Branford et al.
LEUKEMIA (2019)
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients
Friederike Christen et al.
BLOOD (2019)
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
Xi Luo et al.
BLOOD ADVANCES (2019)
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation
Reina Nagase et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents
Matthieu Duchmann et al.
EBIOMEDICINE (2018)
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes
Yoshihiro Hayashi et al.
CANCER DISCOVERY (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
Chronic immune response dysregulation in MDS pathogenesis
Laura Barreyro et al.
BLOOD (2018)
Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima et al.
NATURE GENETICS (2017)
Myeloid neoplasms with germ line RUNX1 mutation
Yoshihiro Hayashi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
RUNX1 cooperates with FLT3-ITD to induce leukemia
Kira Behrens et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Overexpression of RUNX1 short isoform has an important role in the development of myelodysplastic/myeloproliferative neoplasms
Hiroko Sakurai et al.
BLOOD ADVANCES (2017)
Runt-Related Transcription Factor 1 Regulates LPS-Induced Acute Lung Injury via NF-κB Signaling
Xiaoju Tang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
Mouse RUNX1C regulates premegakaryocytic/erythroid output and maintains survival of megakaryocyte progenitors
Julia E. Draper et al.
BLOOD (2017)
Clinical significance of somatic mutation in unexplained blood cytopenia
Luca Malcovati et al.
BLOOD (2017)
RUNX1 Mutations in Inherited and Sporadic Leukemia
Dana C. Bellissimo et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia
Karl Haslam et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia
I. Antony-Debre et al.
LEUKEMIA (2016)
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
V. I. Gaidzik et al.
LEUKEMIA (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia
Lin Fu et al.
ONCOTARGET (2016)
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
Anuradha Illendula et al.
EBIOMEDICINE (2016)
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia
Jane E. Churpek et al.
BLOOD (2015)
MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance
Brian Kwok et al.
BLOOD (2015)
RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation
Olga N. Kuvardina et al.
BLOOD (2015)
Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells
Xiongwei Cai et al.
CELL STEM CELL (2015)
Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes
Shu-Chun Tsai et al.
CLINICAL CANCER RESEARCH (2015)
7Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
Maria Teresa Esposito et al.
NATURE MEDICINE (2015)
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R. Coleman Lindsley et al.
BLOOD (2015)
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia
Ileana Antony-Debre et al.
BLOOD (2015)
Posttranslational modifications of RUNX1 as potential anticancer targets
S. Goyama et al.
ONCOGENE (2015)
Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations
Allison H. West et al.
BONE MARROW NICHE, STEM CELLS, AND LEUKEMIA: IMPACT OF DRUGS, CHEMICALS, AND THE ENVIRONMENT (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells
S. H. Lee et al.
ONCOGENE (2014)
Recurrent CDC25C mutations drive malignant transformation in FPD/AML
Akihide Yoshimi et al.
NATURE COMMUNICATIONS (2014)
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation
Goro Sashida et al.
NATURE COMMUNICATIONS (2014)
Identification of a Dynamic Core Transcriptional Network in t(8;21) AML that Regulates Differentiation Block and Self-Renewal
Anetta Ptasinska et al.
CELL REPORTS (2014)
RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes
Yuka Harada et al.
BLOOD (2013)
Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an AML1-ETO mouse model
Nina Cabezas-Wallscheid et al.
EMBO MOLECULAR MEDICINE (2013)
Runt-related Transcription Factor 1 (RUNX1) Stimulates Tumor Suppressor p53 Protein in Response to DNA Damage through Complex Formation and Acetylation
Dan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells
Susumu Goyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
An evolutionary perspective on chronic myelomonocytic leukemia
R. Itzykson et al.
LEUKEMIA (2013)
A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis
Xiao-Jian Sun et al.
NATURE (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Atlas of Genetics and Cytogenetics in Oncology and Haematology in 2013
Jean-Loup Huret et al.
NUCLEIC ACIDS RESEARCH (2013)
Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia
Li-Juan Zhao et al.
BLOOD (2012)
Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression
Dominique Bluteau et al.
BLOOD (2012)
Runx2 Protein Stabilizes Hypoxia-inducible Factor-1α through Competition with von Hippel-Lindau Protein (pVHL) and Stimulates Angiogenesis in Growth Plate Hypertrophic Chondrocytes
Sun-Hee Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Runx1 Deficiency in CD4+ T Cells Causes Fatal Autoimmune Inflammatory Lung Disease Due to Spontaneous Hyperactivation of Cells
Won Fen Wong et al.
JOURNAL OF IMMUNOLOGY (2012)
C-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells
Y. Satoh et al.
LEUKEMIA (2012)
RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization
Larissa Lordier et al.
NATURE COMMUNICATIONS (2012)
AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors
Masahiro Nakagawa et al.
BLOOD (2011)
Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations
Ulrike Bacher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases
V. Grossmann et al.
LEUKEMIA (2011)
C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice
Yue-Ying Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation
Lan Wang et al.
SCIENCE (2011)
Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis
Bindya Jacob et al.
BLOOD (2010)
Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency
Gauthami Jalagadugula et al.
BLOOD (2010)
Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells
Grant A. Challen et al.
EXPERIMENTAL HEMATOLOGY (2010)
Core Binding Factor at the Crossroads: Determining the Fate of the HSC
Kevin A. Link et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Indispensable Role of the Runx1-Cbfβ Transcription Complex for In Vivo-Suppressive Function of FoxP3+ Regulatory T Cells
Akihiko Kitoh et al.
IMMUNITY (2009)
Molecular Pathways Mediating MDS/AML With Focus on AML1/RUNX1 Point Mutations
Yuka Harada et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergroup
Thomas Prebet et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis
X. Liu et al.
LEUKEMIA (2009)
Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter
Michael J. Chen et al.
NATURE (2009)
The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage
Christophe Lancrin et al.
NATURE (2009)
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
Naoko Watanabe-Okochi et al.
BLOOD (2008)
Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer
Wade T. Nottingham et al.
BLOOD (2007)
Development of megakaryoblastic leukaemia in Runx1-Evi1 knock-in chimaeric mouse
K. Maki et al.
LEUKEMIA (2006)
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.
S Nishida et al.
BLOOD (2006)
The tetramer structure of the Nervy homology two domain, NHR2, is critical for AM1/ETO's activity
YZ Liu et al.
CANCER CELL (2006)
KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21):: a study of the Japanese Childhood AML Cooperative Study Group
A Shimada et al.
BLOOD (2006)
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
BF Goemans et al.
LEUKEMIA (2005)
The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice
C Schessl et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
JD Growney et al.
BLOOD (2005)
High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia
H Harada et al.
BLOOD (2004)
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis
M Ichikawa et al.
NATURE MEDICINE (2004)
t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia
CC Yin et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice
TS Fenske et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Nomenclature for Runt-related (RUNX) proteins
AJ van Wijnen et al.
ONCOGENE (2004)
An activated receptor tyrosine kinase, TEL/PDGFβR cooperates with AML1/ETO to induce acute myeloid leukemia in mice
JL Grisolano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The t(8;21) fusion protein contacts co-repressors and histone deacetylases to repress the transcription of the p14ARF tumor suppressor
SW Hiebert et al.
BLOOD CELLS MOLECULES AND DISEASES (2003)
Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia
H Harada et al.
BLOOD (2003)
The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms
J Rennert et al.
BMC EVOLUTIONARY BIOLOGY (2003)
Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation
CG de Guzman et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia
M Higuchi et al.
CANCER CELL (2002)
AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations
YZ Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1
D Levanon et al.
GENE (2001)
Share Paper
